Theracell Advanced Biotechnology is a leading biotechnology company based in Greece. Established in 2013, it specializes in the development of innovative cellular and gene therapy products and is involved in the commercialization of a diverse pipeline of Cell and Gene Therapy (CGT) products. The company’s therapeutic portfolio spans the areas of Orthopedics, Dermatology, Nephrology, Immuno-Oncology, and Tissue Repair and Regeneration.
Through strategic partnerships Theracell Advanced Biotechnology participates in the global vision of the realization of Personalized Medicine tailored to individual patient needs. In 2020 the formation of its key partnership with Orgenesis (www.orgenesis.com), became the basis for expansion of the therapeutic pipeline, with novel cell and gene therapy products developed using tailored processes to meet patients’ needs.